Pompano Beach, Fla., July 20, 2015 (GLOBE NEWSWIRE) -- DS Healthcare Group, Inc. (NASDAQ:DSKX), has launched its first campaign for its clinically proven eyelash stimulating product Spectral.Lash in Brazil’s Drogaria Iguatemi, the leading high-end retail drugstore chain in Sao Paulo and Rio de Janeiro, Brazil.
The campaign features Spectral.Lash in floor-to-ceiling displays throughout its premium high-traffic prestigious locations, showcases Spectral.Lash on the cover of its monthly magazine and features the product on the company’s home page. The campaign has marked the launch of the highly anticipated introduction of Spectral.Lash and has set sales records throughout key markets.
“The rollout of Spectral.Lash has blown away our greatest expectations. We believe this product will continue to drive considerable revenue going forward. This product alone could represent as much as 30% of sales in Brazil, given Brazilian’s obsession with their appearance” commented Leonardo Chiacchio CEO of DS Laboratories do Brasil. “We continue to increase our presence throughout Brazil’s leading pharmacy chains and expect to be present in over 1000 locations in the next 12 months” concluded Chiacchio.
Daniel Khesin, President and CEO of DS Healthcare added, “We expect Brazil to represent one of the largest growth drivers for DS Healthcare. With the Brazilian cosmetic market leading second only to the US in size it is an ideal market for our products”.
The Sao Paulo metropolitan area has a population of 20 million, in one of the fastest growing beauty markets in the world. According to a U.S. Department of Commerce report titled, Doing Business in Brazil, "Hair care products make up the largest segment of the Brazilian cosmetics and toiletries market. Shampoo sales, both imported and locally made, constitute about 50 percent of domestic sales; they are divided evenly between Brazilian and well-known multinational suppliers.”
Drogaria Iguatemi is Brazil’s most affluent chain of pharmacies. Selecting to carry only the most important brands in medicine, cosmetics, derma-cosmetics and skin care products in the world. http://www.drogariaiguatemi.com.br
In an independent clinical study, patients using Spectral.Lash, a cutting-edge treatment from DS Laboratories, resulted in 100% of users experiencing 25% thicker eyelashes within four weeks. Spectral.Lash deploys a breakthrough peptide complex, and scientists believe that peptides, composed of structural amino acids, work by stimulating the expression of keratin genes and by improving overall eyelid health.
About DS Healthcare Group
DS Healthcare Group Inc. leads in the development of biotechnology for topical therapies. It markets through online and specialty retailers, distributors, cosmetics wholesalers, and salons. Its research has led to a highly innovative portfolio of personal care products and additional innovations in pharmaceutical projects. For more information on DS Health Group's flagship brand, visit www.dslaboratories.com
Forward-looking statements
Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies, and are generally preceded by words such as "future," "plan" or "planned," "expects," or "projected." These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing and marketing products, intense competition, and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, which are available at http://www.sec.gov